Clinical trials: Toripalimab, completed
Nasopharyngeal Carcinoma (NPC), Radiation-induced Oral Mucositis
Pre-Radiotherapy n-6/n-3 Fatty Acid Ratio Predicts Severe Oral Mucositis in Nasopharyngeal Carcinoma
The goal of this clinical trial is to learn if the balance of omega-6 and omega-3 fats in red blood cells can predict severe mouth sores caused by radiation therapy in people with locally advanced nasopharyngeal carcinoma (a type…
- Conditions
- Nasopharyngeal Carcinoma (NPC), Radiation-induced Oral Mucositis, Head and Neck Neoplasms
- Trial name
- NCT07920250
- Testing
- Toripalimab (240mg day1, Q3W*3cycle), Cisplatin (80 mg/m2), Nab-paclitaxel
- Where
- China
- Volunteers
- 210 people, healthy volunteers welcome
- Sponsor
- Affiliated Hospital of Guangdong Medical University